SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1483.75-55.85 (-3.63 %)
PREV CLOSE ( ) 1539.60
OPEN PRICE ( ) 1560.05
BID PRICE (QTY) 1484.35 (9)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 71852
TODAY'S LOW / HIGH ( )1477.65 1560.70
52 WK LOW / HIGH ( )922.55 1638.7
NSE1484.65-55.45 (-3.6 %)
PREV CLOSE( ) 1540.10
OPEN PRICE ( ) 1562.00
BID PRICE (QTY) 1484.65 (506)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 9160422
TODAY'S LOW / HIGH( ) 1477.70 1562.45
52 WK LOW / HIGH ( )922.45 1638.85
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax94084.3044813.2027993.7050095.9038102.00
Adjustment27225.6019749.5018098.5019925.4019686.60
Changes In working Capital-56618.2015590.5025640.908985.50-26960.00
Cash Flow after changes in Working Capital64691.7080153.2071733.1079006.8030828.60
Cash Flow from Operating Activities49593.3089845.4061703.7065547.7021964.50
Cash Flow from Investing Activities-79436.80-57247.405362.20-25888.40-6812.50
Cash Flow from Financing Activities23760.70-51934.60-59804.80-57151.40-27305.20
Net Cash Inflow / Outflow-6082.80-19336.607261.10-17492.10-12153.20
Opening Cash & Cash Equivalents45082.5062730.3056766.1070623.0079064.50
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidations5666.90414.50NANA455.20
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations1570.701274.30-1296.903635.203256.50
Closing Cash & Cash Equivalent46237.3045082.5062730.3056766.1070623.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.